Review on molecular and chemopreventive potential of nimbolide in cancer

Perumal Elumalai1, Jagadeesan Arunakaran1

  • 1Department of Endocrinology, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai 600113, India.

Genomics & Informatics
|February 24, 2015
PubMed

Insights

Nimbolide, derived from neem leaves, shows promising anticancer activity by inhibiting cancer cell proliferation and metastasis. This natural compound offers a potential non-toxic alternative for cancer treatment.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer remains a significant global health challenge with incompletely understood molecular mechanisms.
  • Current allopathic cancer therapies can be costly, induce side effects, and potentially disrupt gene function.
  • There is a need for non-toxic, effective, and affordable cancer treatment modalities.

Purpose of the Study:

  • To review the molecular targets underlying the anticancer activity of nimbolide.
  • To highlight nimbolide's potential as a natural therapeutic agent against cancer progression.
  • To consolidate current knowledge on nimbolide's mechanisms of action.

Main Methods:

  • Literature review of studies on nimbolide and its effects on cancer cells.
  • Analysis of research focusing on nimbolide's impact on apoptosis and cell cycle.
  • Examination of studies investigating nimbolide's inhibition of cancer-related signaling pathways.

Main Results:

  • Nimbolide, a neem-derived limnoid, demonstrates significant anticancer properties.
  • Nimbolide has been shown to inhibit cancer cell proliferation and metastasis.
  • Key mechanisms include the induction of apoptosis and cell cycle arrest.

Conclusions:

  • Nimbolide exhibits potent anticancer effects through multiple molecular targets.
  • Its ability to induce apoptosis and cell cycle arrest makes it a promising candidate for cancer therapy.
  • Nimbolide represents a potential safe, effective, and affordable natural remedy for controlling cancer progression.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
785
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K